MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics EBITDA per Share 2011-2026 | AXDX
Annual EBITDA per Share Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.15 | -0.28 | -1.09 | -1.29 | -1.43 | -1.15 | -1.25 | -0.972 | -0.702 | -0.398 | -0.253 | -0.0142 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0142 | -1.43 | -0.748 |
Quarterly EBITDA per Share Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.33 | -0.36 | - | -0.99 | -1.11 | -0.16 | - | -1.68 | -2.3 | -0.23 | -0.29 | -0.23 | -0.28 | -0.33 | -0.26 | -0.26 | -0.27 | -0.31 | -0.33 | -0.31 | -0.32 | -0.34 | -0.36 | -0.34 | -0.37 | -0.37 | -0.29 | -0.3 | -0.3 | -0.27 | -0.31 | -0.33 | -0.34 | -0.29 | - | -0.24 | -0.27 | -0.19 | - | -192 | -184 | -134 | - | -93.1 | -95.2 | -86.3 | -0.03 | -0.07 | -0.1 | -0.07 | - | -0.04 | - | -0.04 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.03 | -192 | -17 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.49 | $ 121.22 | 2.51 % | $ 36.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 20.86 | -7.29 % | $ 224 M |  China |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 21.83 | -2.63 % | $ 1.16 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.53 | 4.45 % | $ 2.04 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 25.1 | 2.2 % | $ 697 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 182.98 | 3.41 % | $ 9.07 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 195.02 | 0.64 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.0 | -9.09 % | $ 8.85 M | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 521.78 | 1.19 % | $ 15.1 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 5.04 | 0.8 % | $ 467 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.37 | 2.51 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.47 | 2.49 % | $ 2.05 B | USA |
 |
Illumina
ILMN
|
-3.01 | $ 133.73 | 0.76 % | $ 21.3 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 16.22 | 0.56 % | $ 490 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 29.77 | 3.98 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
0.03 | $ 28.81 | -0.66 % | $ 46.2 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 90.58 | 5.69 % | $ 11.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.83 | - | $ 91.8 K | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.17 | -1.14 % | $ 4.98 M | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.77 | - | $ 282 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 119.35 | 3.26 % | $ 9.84 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 272.2 | 2.19 % | $ 22.6 B | USA |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 52.69 | 0.23 % | $ 2.68 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 122.36 | -2.31 % | $ 5.72 B | USA |
 |
Neuronetics
STIM
|
-0.42 | $ 1.41 | 0.36 % | $ 93 M | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 83.18 | -0.88 % | $ 5.61 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 196.01 | 2.37 % | $ 21.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 525.39 | 1.82 % | $ 198 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 6.09 | 17.76 % | $ 4.79 M | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.71 | 2.13 % | $ 61.9 M | Irlanda |